Author: Sushree Mohanty

Sushree Mohanty first joined Market Realist in 2015. She covered macroeconomics, consumer stocks, and the real estate sector. Currently, Sushree covers the cannabis industry. She has a bachelor's degree in business management, specializing in finance, and is a CFA Level 2 candidate. Sushree also has four years of work experience in retail and operations management.

Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.

Hexo (HEXO) had a hard time last week. A lot of headwinds pulled the stock down. However, the stock rose and closed with a gain of 17% on Thursday.

Cronos Group (CRON) stock rose 33% with a heavy volume in after-hours trading on Wednesday. Marijuana stocks are on a rollercoaster ride.

Aphria (APHA) reported impressive results for the first quarter of fiscal 2020 on Tuesday. The stock has gained 9.6% since its earnings.

Two Pennsylvania senators introduced a comprehensive marijuana legalization bill on Tuesday. Senator Daylin Leach and Sharif Street introduced the bill.

Cannabis edibles legalization is almost here! On Thursday, Canada will finally legalize edibles, infused beverages, and extracts.

Cannabis legalization has taken a back seat in the US. Since the last Democratic debate, there hasn't been much discussion about federal legalization.

Aphria (APHA), a Canada-based global cannabis company, will report its results for the first quarter of fiscal 2020 today after the market opens.

Scandals have engulfed the sector many times, especially for CannTrust, Curaleaf, and Hexo. Could Tilray be next on the cannabis scandal radar?

Cannabis stocks see dark clouds looming. The week ending on October 11 was disastrous for the sector. Hexo stock fell after it withdrew its fiscal 2020 outlook.

On Thursday, Canopy Growth announced that Constellation’s CFO David Klein will be the new chairman of its board effective immediately.